(Beth Israel Deaconess Medical Center) In a paradoxical discovery, a research team led by investigators at Beth Israel Deaconess Medical Center has found that a tumor suppressor protein known as PML appears to be the factor that enables leukemia initiating cells to maintain their quiescence -- the inert state that protects them from being destroyed by cancer therapies.
Post new comment